The University of Kansas Medical Center (KUMC) has filed suit challenging the continuation in 2021 of a nearly 30% cut in Medicare Part B reimbursement for hospitals’ 340B-purchased physician-administered drugs.
KUMC filed the suit Nov. 24 in U.S. District Court for the District of Columbia. The cut has been in place since 2018 and is due to continue next year. The U.S. Supreme Court heard arguments Nov. 30 in a different case challenging the cut’s legality. It is expected to rule early next year.
The University of Kansas Medical Center (KUMC) has filed suit challenging the continuation in 2021 of a nearly 30% cut in Medicare Part B reimbursement for hospitals’ 340B-purchased physician-administered drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.